These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1295439)

  • 1. [Immunology of insulin-dependent diabetes. Towards practical applications].
    Boitard C; Timsit J; Bach J
    Ann Endocrinol (Paris); 1992; 53(3):98-101. PubMed ID: 1295439
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunointervention in newly diagnosed type 1 diabetes].
    Kaupper T; Walter M; Ziegler AG
    Dtsch Med Wochenschr; 2006 Dec; 131(49):2783-8. PubMed ID: 17136660
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnosis and treatment of pre-insulin dependent diabetes.
    Gottlieb PA; Eisenbarth GS
    Annu Rev Med; 1998; 49():391-405. PubMed ID: 9509271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history and prediction of type 1 diabetes.
    Di Mario U; Dotta F
    Ann Ig; 1992; 4(3):153-7. PubMed ID: 1284514
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoreactivity to a 64,000 Mr human islet cell antigen in sera from insulin-dependent diabetes mellitus patients and individuals with abnormal glucose tolerance.
    Baekkeskov S
    Mol Biol Med; 1986 Apr; 3(2):137-42. PubMed ID: 3526081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Screening of pre-diabetes type I: Why? How? Whom?].
    Assan R; Larger E
    Journ Annu Diabetol Hotel Dieu; 1992; ():123-30. PubMed ID: 1495231
    [No Abstract]   [Full Text] [Related]  

  • 7. Towards secondary prevention of Type 1 diabetes.
    David Leslie R
    Diabet Med; 2011 Oct; 28(10):1140. PubMed ID: 21848636
    [No Abstract]   [Full Text] [Related]  

  • 8. [Screening of pre-diabetes type I: possibilities and limits].
    Timsit J; Caillat-Zucman S; Boitard C; Bach JF
    Journ Annu Diabetol Hotel Dieu; 1992; ():131-8. PubMed ID: 1495232
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological approaches to the prevention of autoimmune diabetes.
    Winter WE; House DV; Schatz D
    Drugs; 1997 Jun; 53(6):943-56. PubMed ID: 9179526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I diabetes: clinical implications of autoimmunity.
    Eisenbarth GS
    Hosp Pract (Off Ed); 1987 Sep; 22(9):167-71, 174, 177 passim.. PubMed ID: 3114287
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunointervention in type 1 (insulin-dependent) diabetes mellitus.
    Keymeulen B; Somers G
    Acta Clin Belg; 1993; 48(2):86-95. PubMed ID: 8392249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Etiology and pathogenesis of type I diabetes].
    Ziegler AG
    Z Gesamte Inn Med; 1993 Mar; 48(3):100-7. PubMed ID: 8475631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trials of immunotherapy to preserve beta-cell function of prediabetic and new-onset patient trials.
    Eisenbarth GS
    Curr Diab Rep; 2004 Apr; 4(2):85-6. PubMed ID: 15035966
    [No Abstract]   [Full Text] [Related]  

  • 14. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes.
    Naserke HE; Ziegler AG; Lampasona V; Bonifacio E
    J Immunol; 1998 Dec; 161(12):6963-9. PubMed ID: 9862731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predictability of insulin-dependent diabetes mellitus.
    Riley WJ; Maclaren NK; Silverstein JH
    Adv Pediatr; 1988; 35():167-87. PubMed ID: 3055857
    [No Abstract]   [Full Text] [Related]  

  • 16. [Result of 3 years of screening for preclinical phase of juvenile insulin-dependent diabetes mellitus].
    Lesage C; Boitard C; Carel JC; Dauvergne M; Roger M; Chaussain JL; Bougnères PF
    Arch Fr Pediatr; 1990 Dec; 47(10):709-13. PubMed ID: 2082843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunointervention in insulin dependent diabetes: implications for the epidemiology of the disease.
    Visalli N; Pozzilli P; Boccuni ML; Suppa MA; Messina R; Buzzetti R; Andreani D
    Ann Ig; 1992; 4(3):159-63. PubMed ID: 1284515
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical aspects of the immunopathogenesis of type I diabetes mellitus].
    Scherbaum WA
    Internist (Berl); 1987 Apr; 28(4):228-35. PubMed ID: 3298122
    [No Abstract]   [Full Text] [Related]  

  • 19. Latent autoimmune diabetes of adults (LADA).
    Ola TO; Gigante A; Leslie RD
    Nutr Metab Cardiovasc Dis; 2006 Apr; 16(3):163-7. PubMed ID: 16580583
    [No Abstract]   [Full Text] [Related]  

  • 20. Progression of autoimmune diabetes: slowly progressive insulin-dependent diabetes mellitus or latent autoimmune diabetes of adult.
    Beyan H; Ola T; David R; Leslie G
    Ann N Y Acad Sci; 2006 Oct; 1079():81-9. PubMed ID: 17130535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.